Accounting for patient preferences: “Nothing for us, without us” | IMI project PREFER has published recommendations on when and how best to capture patient perspectives on the benefits and risks of medicines, and the project’s framework has got a nod of approval from the European Medicines Agency. | |
| | | |
| | |